Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SP140 nuclear body protein like (SP140L) is a member of the SP100 protein family, characterized by domain features such as a plant homeodomain (PHD), a bromodomain (BRD), and zinc finger motifs similar to the canonical SP140 and SP100 proteins[4][2]. While SP140L’s direct function remains unclarified, these domains suggest chromatin binding and potential transcriptional regulatory functions, possibly acting as a chromatin 'reader'—paralleling SP140, which is implicated as a transcriptional co-regulator in immune cells and is interferon-inducible[2]. The SP100/SP140 protein family is known to localize to nuclear bodies and participate in immune-specific chromatin regulation, but SP140L has not yet been linked to specific immune diseases, marker use, or therapeutic interventions[4]. The protein is likely expressed in the nucleus, but tissue- and isoform-specific expression details are limited and it lacks specific experimental functional annotation or clinical data as of current science[4][2]. Note: - Detailed studies, drug relationships, or clinical applications for SP140L are lacking; most information about biological function and classification is inferred from similarity to SP140 and SP100[4][2]. - Take care not to confuse SP140L with SP140, which is a separate—though related and better-studied—immune gene linked to multiple sclerosis, Crohn's disease, and leukemia[3][2]. - The entries for various isoforms (SP140L-1, SP140L-2, etc.) indicate alternative splicing rather than distinct targets. If you require information on the related and better-understood SP140, substantial functional and disease role data are available; please specify if that is needed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SP140 nuclear body protein like (SP140L).